The Body Composition Research Bundle combines two complementary research compounds targeting distinct metabolic pathways — growth hormone releasing hormone (GHRH) signaling and GLP receptor agonism. This bundle provides investigators with compounds for studying body composition regulation through dual-pathway modulation.
Research compounds — for laboratory use only.
Body Composition Research Bundle
Dual-Pathway Metabolic Research Collection — For Research Use Only
Bundle Contents
- Tesamorelin 10mg — GHRH analog studied for growth hormone axis signaling and lipid metabolism research
- GLP-3 5mg — GLP receptor agonist studied for metabolic regulation and energy balance research
- Bacteriostatic Water 10ml — Reconstitution solvent
- Acetic Acid 0.6% 3ml — Reconstitution solvent for compounds requiring acidic pH
Research Context
Body composition research examines the interplay between lipolysis, lipogenesis, growth hormone signaling, and metabolic rate regulation. Published literature demonstrates that GHRH analogs and GLP receptor agonists act through complementary mechanisms — GHRH signaling modulates pulsatile GH release affecting adipose tissue metabolism, while GLP receptor activation influences energy homeostasis through distinct neuroendocrine pathways.
This multi-compound format enables researchers to investigate pathway interactions, compare receptor-selective effects, and design experiments examining synergistic or independent contributions to metabolic signaling.
Storage
Lyophilized compounds are stable at room temperature for limited handling periods. For maximum longevity, store frozen (-20°C or standard freezer). After reconstitution, refrigerate (2-8°C) and follow compound-specific handling procedures.
FOR RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION
